Canada Life’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $68.3M | Sell |
1,085,764
-73,332
| -6% | -$5.87M | 0.12% | 139 |
|
|
2025
Q4 | $111M | Sell |
1,159,096
-801,463
| -41% | -$78.6M | 0.19% | 104 |
|
|
2025
Q3 | $190M | Buy |
1,960,559
+36,150
| +2% | +$3.74M | 0.27% | 65 |
|
|
2025
Q2 | $207M | Buy |
1,924,409
+101,925
| +6% | +$10.3M | 0.33% | 59 |
|
|
2025
Q1 | $184M | Buy |
1,822,484
+43,522
| +2% | +$4.38M | 0.32% | 58 |
|
|
2024
Q4 | $159M | Sell |
1,778,962
-11,410
| -0.6% | -$1M | 0.27% | 61 |
|
|
2024
Q3 | $150M | Buy |
1,790,372
+43,707
| +3% | +$3.45M | 0.26% | 68 |
|
|
2024
Q2 | $135M | Buy |
1,746,665
+302,098
| +21% | +$22.1M | 0.25% | 71 |
|
|
2024
Q1 | $99M | Buy |
1,444,567
+15,270
| +1% | +$982K | 0.2% | 102 |
|
|
2023
Q4 | $82.2M | Buy |
1,429,297
+157,599
| +12% | +$8.41M | 0.18% | 111 |
|
|
2023
Q3 | $67.2M | Buy |
1,271,698
+89,214
| +8% | +$4.68M | 0.16% | 120 |
|
|
2023
Q2 | $64.3M | Buy |
1,182,484
+130,469
| +12% | +$6.81M | 0.15% | 127 |
|
|
2023
Q1 | $52.7M | Sell |
1,052,015
-2,357
| -0.2% | -$111K | 0.13% | 164 |
|
|
2022
Q4 | $49M | Sell |
1,054,372
-19,101
| -2% | -$827K | 0.13% | 170 |
|
|
2022
Q3 | $41.6M | Sell |
1,073,473
-131
| -0% | -$5.25K | 0.12% | 178 |
|
|
2022
Q2 | $40M | Buy |
1,073,604
+42,235
| +4% | +$1.72M | 0.11% | 198 |
|
|
2022
Q1 | $48.2M | Buy |
1,031,369
+97
| +0% | +$4.2K | 0.1% | 218 |
|
|
2021
Q4 | $43.7M | Buy |
1,031,272
+26,784
| +3% | +$1.13M | 0.09% | 230 |
|
|
2021
Q3 | $43.9M | Buy |
1,004,488
+11,295
| +1% | +$500K | 0.1% | 210 |
|
|
2021
Q2 | $42.4M | Sell |
993,193
-358
| -0% | -$15.1K | 0.1% | 225 |
|
|
2021
Q1 | $38.2M | Buy |
993,551
+32,902
| +3% | +$1.25M | 0.09% | 232 |
|
|
2020
Q4 | $34.5M | Buy |
960,649
+137,766
| +17% | +$4.97M | 0.06% | 295 |
|
|
2020
Q3 | $31.4M | Buy |
822,883
+85,530
| +12% | +$3.3M | 0.07% | 269 |
|
|
2020
Q2 | $25.8M | Sell |
737,353
-34,326
| -4% | -$1.24M | 0.06% | 296 |
|
|
2020
Q1 | $25.3M | Sell |
771,679
-9,673
| -1% | -$378K | 0.07% | 277 |
|
|
2019
Q4 | $35.1M | Sell |
781,352
-64,554
| -8% | -$2.7M | 0.08% | 262 |
|
|
2019
Q3 | $34.4M | Sell |
845,906
-8,766
| -1% | -$371K | 0.08% | 262 |
|
|
2019
Q2 | $36.7M | Sell |
854,672
-253,692
| -23% | -$9.76M | 0.08% | 245 |
|
|
2019
Q1 | $42.4M | Buy |
1,108,364
+249,144
| +29% | +$9.52M | 0.11% | 197 |
|
|
2018
Q4 | $28.9M | Sell |
859,220
-10,527
| -1% | -$382K | 0.08% | 237 |
|
|
2018
Q3 | $33.5M | Sell |
869,747
-119,564
| -12% | -$4.18M | 0.08% | 245 |
|
|
2018
Q2 | $32.4M | Buy |
989,311
+3,171
| +0.3% | +$95.6K | 0.08% | 262 |
|
|
2018
Q1 | $27M | Sell |
986,140
-11,678
| -1% | -$317K | 0.07% | 290 |
|
|
2017
Q4 | $24.7M | Buy |
997,818
+6,127
| +0.6% | +$169K | 0.06% | 312 |
|
|
2017
Q3 | $28.5M | Buy |
991,691
+17,839
| +2% | +$493K | 0.07% | 281 |
|
|
2017
Q2 | $27M | Sell |
973,852
-158,445
| -14% | -$4.21M | 0.07% | 281 |
|
|
2017
Q1 | $28.1M | Sell |
1,132,297
-10,317
| -0.9% | -$251K | 0.08% | 259 |
|
|
2016
Q4 | $24.8M | Sell |
1,142,614
-98,676
| -8% | -$2.15M | 0.07% | 275 |
|
|
2016
Q3 | $29.5M | Buy |
1,241,290
+41,787
| +3% | +$997K | 0.09% | 240 |
|
|
2016
Q2 | $27.9M | Buy |
1,199,503
+414,463
| +53% | +$8.97M | 0.08% | 244 |
|
|
2016
Q1 | $14.8M | Buy |
785,040
+36,804
| +5% | +$646K | 0.05% | 324 |
|
|
2015
Q4 | $13.8M | Buy |
748,236
+39,400
| +6% | +$706K | 0.05% | 325 |
|
|
2015
Q3 | $11.6M | Sell |
708,836
-23,644
| -3% | -$404K | 0.05% | 353 |
|
|
2015
Q2 | $12.9M | Sell |
732,480
-1,537
| -0.2% | -$27.5K | 0.04% | 370 |
|
|
2015
Q1 | $13M | Sell |
734,017
-28,802
| -4% | -$455K | 0.04% | 382 |
|
|
2014
Q4 | $10.1M | Sell |
762,819
-101,586
| -12% | -$1.3M | 0.03% | 427 |
|
|
2014
Q3 | $10.2M | Sell |
864,405
-32,081
| -4% | -$404K | 0.03% | 417 |
|
|
2014
Q2 | $11.4M | Buy |
896,486
+49,646
| +6% | +$646K | 0.04% | 398 |
|
|
2014
Q1 | $11.4M | Buy |
846,840
+102,884
| +14% | +$1.35M | 0.04% | 393 |
|
|
2013
Q4 | $8.99M | Buy |
743,956
+60,553
| +9% | +$715K | 0.03% | 440 |
|
|
2013
Q3 | $8.01M | Buy |
683,403
+622,049
| +1,014% | +$6.73M | 0.03% | 437 |
|
|
2013
Q2 | $569K | Buy |
+61,354
| New | +$520K | ﹤0.01% | 522 |
|
Other funds holding BSX
VCM
VPM
Canada Life's BSX Position: Q1 2026 in Review
Canada Life reduced its Boston Scientific (BSX) stake by 6.3% in Q1 2026, selling an estimated $5.87M and leaving 1,085,764 shares worth $68.3M. The position accounts for 0.12% of the portfolio, ranked #139.
Canada Life first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $207M in Q2 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Canada Life held 1,085,764 shares of Boston Scientific worth $68.3M as of Q1 2026.
- Canada Life sold 73,332 Boston Scientific shares in Q1 2026, an estimated $5.87M.
- Boston Scientific made up 0.12% of Canada Life's portfolio in Q1 2026, its #139 holding.
- Canada Life first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Canada Life's Boston Scientific position peaked at $207M in Q2 2025.
- 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.